The One Lambda™ C1qScreen™ assay combines the sensitivity of Luminex® solid-phase technology with the specificity of anti-HLA single antigen detection for identifying complement-binding donor-specific antibody (DSA).
The C1qScreen assay helps examine the possible involvement of complement-binding antibody in antibody-mediated rejection. Using this assay, the presence of complement-binding (C1q) antibodies can be identified and monitored in sera, providing information for building better antibody profiles.